Efforts of industry-academia collaboration to study how to utilize JMP Clinical in various scenes of clinical trials
Hayashi Hayashi General Manager, Development Strategy Headquarters, A-to-Healthcare Co., Ltd.
In many occasions of clinical trials, there are many opportunities to confirm clinical trial data.During the clinical trial, a blinded review by CRA, DM, STAT and centralized data review for early detection of risks are being conducted.After the completion of the clinical trial, STAT, MW grasp the results of clinical trials to prepare CSR and CTD, exploratory data review for planning the next clinical trial, etc. are carried out.JMP Clinical is excellent in visualizing data, and if you want to check details during data review, you can quickly check related information.In addition, because it can be operated by GUI, even those who do not write any programming languages such as SAS are expected to be able to easily review data even for people of various job types.In order to investigate various ways of utilizing JMP Clinical in various occasions in clinical trials by members of various backgrounds beyond occupation types, organizations, and companies, AGATO health care is a place for sharing information sharing between industry and university We are planning to provide.In this presentation, we will introduce our efforts.
